HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive: Of therapeutic interest, the deletion of HIF-1α in a mouse model of human CML has been observed to inhibit the cell cycle progression and induce the apoptosis via an induction of p16INK4A and p19ARF tumour suppressor proteins in LSCs [55].